By Roshan Fernandez
Shares of Steris gained after the medical-device company beat analysts' expectations for its fourth-quarter per share results.
Shares climbed 5.5%, to $240, after hours Wednesday, and the stock is up about 11% since the beginning of the year.
The Dublin company reported a fiscal fourth-quarter profit of $145.7 million, or $1.48 a share, compared to a loss of $1.4 million, or 1 cent a share, a year earlier.
Excluding one-time items, per-share earnings were $2.74, beating analysts' expectations of $2.60, according to FactSet.
Revenue rose to $1.48 billion from $1.42 billion during the year-ago quarter. Analysts expected $1.47 billion.
That was driven in part by a rise in applied sterilization-technologies sales, which were up 9.2% compared to last year.
The company expects revenue for fiscal-year 2026 to increase 6% to 7%. That would be between about $5.79 billion to $5.84 billion, based on the $5.46 billion the company reported in revenue for fiscal-year 2025. That beats the $5.78 billion projected by analysts.
Adjusted earnings per share are expected to be between $9.90 and $10.15 for the fiscal year. Analysts were looking for $10 in adjusted per-share earnings.
Steris said its fiscal-year 2026 outlook includes an expected $30 million pre-tax hit to its profits as a result of tariffs.
Write to Roshan Fernandez at roshan.fernandez@wsj.com
(END) Dow Jones Newswires
May 14, 2025 17:59 ET (21:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。